UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Study

Journal of clinical oncology, 2008-10, Vol.26 (29), p.4708-4713

2008

Volltextzugriff (PDF)

Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver Metastases

Journal of clinical oncology, 2009-04, Vol.27 (10), p.1572-1578

2009

Volltextzugriff (PDF)

Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases

Journal of clinical oncology, 2009-04, Vol.27 (10), p.1579-1584

2009

Volltextzugriff (PDF)

Treatment of advanced thyroid cancer with axitinib: Phase 2 study with pharmacokinetic/pharmacodynamic and quality‐of‐life assessments

Cancer, 2014-09, Vol.120 (17), p.2694-2703

2014

Volltextzugriff (PDF)

Phase II Trial of Gefitinib 250 mg Daily in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

Clinical cancer research, 2005-12, Vol.11 (23), p.8418-8424

2005

Volltextzugriff (PDF)

A phase II study of the orally administered negative enantiomer of gossypol (AT-101), a BH3 mimetic, in patients with advanced adrenal cortical carcinoma

Investigational new drugs, 2019-08, Vol.37 (4), p.755-762

2019

Volltextzugriff (PDF)

Approach to the Thyroid Cancer Patient with Extracervical Metastases

The journal of clinical endocrinology and metabolism, 2010-03, Vol.95 (3), p.987-993

2010

Volltextzugriff (PDF)

Phase I trial of vandetanib in combination with gemcitabine and capecitabine in patients with advanced solid tumors with an expanded cohort in pancreatic and biliary cancers

Investigational new drugs, 2016-04, Vol.34 (2), p.176-183

2016

Volltextzugriff (PDF)

Impact of Radiation Dose on Postoperative Complications in Esophageal and Gastroesophageal Junction Cancers

Frontiers in oncology, 2021-03, Vol.11, p.614640-614640

2021

Volltextzugriff (PDF)

Immune Reconstitution Inflammatory Syndrome Associated with Kaposi Sarcoma during Potent Antiretroviral Therapy

Clinical infectious diseases, 2004-12, Vol.39 (12), p.1852-1855

2004

Volltextzugriff (PDF)

A Phase II Trial of Bexarotene for Advanced Differentiated Thyroid Cancer

Thyroid (New York, N.Y.), 2015-05, Vol.25 (5), p.563-564

2015

Volltextzugriff (PDF)

Gefitinib plus cisplatin and radiotherapy in previously untreated head and neck squamous cell carcinoma: A phase II, randomized, double-blind, placebo-controlled study

Radiotherapy and oncology, 2011-07, Vol.100 (1), p.62-69

2011

Volltextzugriff (PDF)

Survival and Patterns of Relapse in Patients With Oral Tongue Cancer

Journal of oral and maxillofacial surgery, 2010-03, Vol.68 (3), p.584-589

2010

Volltextzugriff (PDF)

Phase I Trial of Gefitinib in Combination With Radiation or Chemoradiation for Patients With Locally Advanced Squamous Cell Head and Neck Cancer

Journal of clinical oncology, 2007-11, Vol.25 (31), p.4880-4886

2007

Volltextzugriff (PDF)

The role of folates in squamous cell carcinoma of the head and neck

Cancer detection and prevention, 2005, Vol.29 (1), p.46-53

Kane, Madeleine A.

2005

Volltextzugriff (PDF)

Initial Results of a Phase I Dose-Escalation Trial of Concurrent and Maintenance Erlotinib and Reirradiation for Recurrent and New Primary Head-and-Neck Cancer

International journal of radiation oncology, biology, physics, 2010-11, Vol.78 (4), p.1020-1025

2010

Volltextzugriff (PDF)

Final Report of a Phase I Trial of Olaparib with Cetuximab and Radiation for Heavy Smoker Patients with Locally Advanced Head and Neck Cancer

Clinical cancer research, 2018-10, Vol.24 (20), p.4949-4959

2018

Volltextzugriff (PDF)

A Phase II Multi-institutional Trial of Chemoradiation Using Weekly Docetaxel and Erythropoietin for High-Risk Postoperative Head and Neck Cancer Patients

International journal of radiation oncology, biology, physics, 2007-04, Vol.67 (5), p.1323-1331

2007

Volltextzugriff (PDF)

How Should Clinicians Respond to Race-Based Algorithms as Sources of Iatrogenic Harm?

AMA journal of ethics, 2022-08, Vol.24 (8), p.E720-728

2022

Volltextzugriff (PDF)

Chemoprevention of squamous cell carcinoma of the oral cavity

Otolaryngologic clinics of North America, 2006-04, Vol.39 (2), p.349-363

2006

Volltextzugriff (PDF)

Inhibition of proliferation of human small cell lung cancer cells expressing an autocrine system for gastrin releasing peptide by antisense oligodeoxynucleotides to gastrin releasing peptide receptor

Lung cancer (Amsterdam, Netherlands), 2002-06, Vol.36 (3), p.235-242

2002

Volltextzugriff (PDF)

Dexamethasone regulation of gastrin-releasing peptide receptor in human lung cells

Lung cancer (Amsterdam, Netherlands), 2004, Vol.43 (1), p.17-28

2004

Volltextzugriff (PDF)

Transfusion-related acute lung injury (TRALI) following platelet transfusion in a patient receiving high-dose interleukin-2 for treatment of metastatic renal cell carcinoma

Transfusion and apheresis science, 2003-08, Vol.29 (1), p.25-27

2003

Volltextzugriff (PDF)

Nicotine effects on proliferation and the bombesin-like peptide autocrine system in human small cell lung carcinoma SHP77 cells in culture

Lung cancer (Amsterdam, Netherlands), 2000-07, Vol.29 (1), p.1-10

2000

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(78)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(88)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(63)
Life Sciences & Biomedicine
(60)
Humans
(49)
Oncology
(28)
Biological And Medical Sciences
(24)
Female
(24)
Male
(24)
Middle Aged
(21)
Medical Sciences
(20)
Aged
(19)
Adult
(16)
Tumors
(14)
Antineoplastic Agents - Therapeutic Use
(10)
Aged, 80 And Over
(8)
Combined Modality Therapy
(8)
Medicine
(8)
Neoplasm Staging
(8)
Treatment Outcome
(8)
Biochemistry & Molecular Biology
(7)
Endocrinology & Metabolism
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Study

Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver Metastases

Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases

Treatment of advanced thyroid cancer with axitinib: Phase 2 study with pharmacokinetic/pharmacodynamic and quality‐of‐life assessments

Phase II Trial of Gefitinib 250 mg Daily in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

A phase II study of the orally administered negative enantiomer of gossypol (AT-101), a BH3 mimetic, in patients with advanced adrenal cortical carcinoma

Approach to the Thyroid Cancer Patient with Extracervical Metastases

An International Phase 2 Study of Pazopanib in Progressive and Metastatic Thyroglobulin Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid Cancer

Phase I trial of vandetanib in combination with gemcitabine and capecitabine in patients with advanced solid tumors with an expanded cohort in pancreatic and biliary cancers

Impact of Radiation Dose on Postoperative Complications in Esophageal and Gastroesophageal Junction Cancers

Immune Reconstitution Inflammatory Syndrome Associated with Kaposi Sarcoma during Potent Antiretroviral Therapy

A Phase II Trial of Bexarotene for Advanced Differentiated Thyroid Cancer

Gefitinib plus cisplatin and radiotherapy in previously untreated head and neck squamous cell carcinoma: A phase II, randomized, double-blind, placebo-controlled study

Survival and Patterns of Relapse in Patients With Oral Tongue Cancer

Phase I Trial of Gefitinib in Combination With Radiation or Chemoradiation for Patients With Locally Advanced Squamous Cell Head and Neck Cancer

The role of folates in squamous cell carcinoma of the head and neck

Initial Results of a Phase I Dose-Escalation Trial of Concurrent and Maintenance Erlotinib and Reirradiation for Recurrent and New Primary Head-and-Neck Cancer

Final Report of a Phase I Trial of Olaparib with Cetuximab and Radiation for Heavy Smoker Patients with Locally Advanced Head and Neck Cancer

A Phase II Multi-institutional Trial of Chemoradiation Using Weekly Docetaxel and Erythropoietin for High-Risk Postoperative Head and Neck Cancer Patients

How Should Clinicians Respond to Race-Based Algorithms as Sources of Iatrogenic Harm?

Chemoprevention of squamous cell carcinoma of the oral cavity

Inhibition of proliferation of human small cell lung cancer cells expressing an autocrine system for gastrin releasing peptide by antisense oligodeoxynucleotides to gastrin releasing peptide receptor

Dexamethasone regulation of gastrin-releasing peptide receptor in human lung cells

Transfusion-related acute lung injury (TRALI) following platelet transfusion in a patient receiving high-dose interleukin-2 for treatment of metastatic renal cell carcinoma

Nicotine effects on proliferation and the bombesin-like peptide autocrine system in human small cell lung carcinoma SHP77 cells in culture

Suchergebnisse filtern